Structures by: Harmaoui A.
Total: 9
(7<i>R</i>)-6-Methyl-7,9-bis(prop-2-yn-1-yl)-7<i>H</i>,8<i>H</i>,9<i>H</i>-1,2,4-triazolo[4,3-<i>b</i>][1,2,4]triazepin-8-one
C12H11N5O
IUCrData (2016) 1, 8 x161245
a=7.5436(3)Å b=15.6498(6)Å c=10.9701(4)Å
α=90° β=108.3340(10)° γ=90°
6-Methyl-7<i>H</i>-1,2,4-triazolo[4,3-<i>b</i>][1,2,4]triazepin-8(9<i>H</i>)-thione
C6H7N5S
IUCrData (2016) 1, 8
a=6.238(2)Å b=7.234(3)Å c=10.887(4)Å
α=103.331(15)° β=92.329(16)° γ=113.846(15)°
Ethyl (2<i>E</i>)-3-dimethylamino-2-(5-methyl-1,2,4-triazolo[1,5-<i>a</i>]pyrimidin-7-yl)prop-2-enoate
C13H17N5O2
IUCrData (2016) 1, 12 x161946
a=7.1482(15)Å b=10.306(2)Å c=19.705(4)Å
α=90° β=99.711(3)° γ=90°
9-Ethyl-6-methyl-7<i>H</i>-1,2,4-triazolo[4,3-<i>b</i>][1,2,4]triazepin-8(9<i>H</i>)-one
C8H11N5O
IUCrData (2016) 1, 12 x161897
a=7.8989(3)Å b=8.0880(3)Å c=8.2052(3)Å
α=90.297(2)° β=113.319(2)° γ=98.488(2)°
5-Methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl)]sulfinyl}-1-(prop-2-yn-1-yl)-1<i>H</i>-benzimidazole
C20H21N3O3S
IUCrData (2016) 1, 10 x161695
a=4.5974(3)Å b=30.675(2)Å c=13.8090(9)Å
α=90° β=91.9610(10)° γ=90°
4-Amino-5-tetradecylamino-4<i>H</i>-1,2,4-triazol-1-ium chloride
C16H34N5,Cl
IUCrData (2016) 1, 11 x161819
a=21.5980(6)Å b=7.0666(2)Å c=13.3909(4)Å
α=90° β=105.031(2)° γ=90°
7,9-Didodecyl-6-methyl-3<i>H</i>,7<i>H</i>,8<i>H</i>,9<i>H</i>,9a<i>H</i>-[1,2,4]triazolo[4,3-<i>b</i>][1,2,4]triazepin-8-one
C30H55N5O
IUCrData (2016) 1, 10 x161587
a=8.8895(7)Å b=8.9652(7)Å c=19.6555(15)Å
α=95.093(3)° β=95.922(3)° γ=98.563(3)°
(<i>E</i>)-4-Methoxy-3,5-dimethyl-2-[(3-nitrophenyl)ethenyl]pyridine
C16H16N2O3
IUCrData (2016) 1, 12 x161966
a=23.3174(7)Å b=8.2979(2)Å c=7.2260(2)Å
α=90° β=90.8990(10)° γ=90°
6,9-Dimethyl-7<i>H</i>-[1,2,4]triazolo[4,3-<i>b</i>][1,2,4]triazepin-8(9<i>H</i>)-one 0.40-hydrate
C7H9N5O,0.4(H2O)
Acta Crystallographica Section E (2015) 71, 1 o1-o2
a=11.4970(18)Å b=11.4527(18)Å c=14.867(2)Å
α=90.00° β=109.615(4)° γ=90.00°